Celia Suriu

Nahariyya, Z, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

AFTER YEARS OF WANDERING, CHRONIC MYELOMONOCYTIC LEUKEMIA FINALLY FOUND ITS PLACE: A HISTORICAL PERSPECTIVE

AFTER YEARS OF WANDERING, CHRONIC MYELOMONOCYTIC LEUKEMIA FINALLY FOUND ITS PLACE: A HISTORICAL PERSPECTIVE

Journal: Harefuah
Published: May 25, 2025

Can Blood Inflammatory Markers Identify Pregnant Women with Preeclampsia? Still a Controversial Issue.

Can Blood Inflammatory Markers Identify Pregnant Women with Preeclampsia? Still a Controversial Issue.

Journal: The Israel Medical Association journal : IMAJ
Published: September 10, 2024

The Involvement of LAG-3positive Plasma Cells in the Development of Multiple Myeloma.

The Involvement of LAG-3positive Plasma Cells in the Development of Multiple Myeloma.

Journal: International journal of molecular sciences
Published: November 22, 2023

Can an Anemic Patient Be a Partner to Treatment Decision-Making?

Can an Anemic Patient Be a Partner to Treatment Decision-Making?

Journal: The Israel Medical Association journal : IMAJ
Published: November 19, 2023

Ethnic disparities in presentation but not outcome in multiple myeloma patients: a multicenter retrospective study in Northern Israel.

Ethnic disparities in presentation but not outcome in multiple myeloma patients: a multicenter retrospective study in Northern Israel.

Journal: Leukemia & lymphoma
Published: September 15, 2023

The role of blood inflammatory markers in the preoperative diagnosis of acute appendicitis.

The role of blood inflammatory markers in the preoperative diagnosis of acute appendicitis.

Journal: International journal of laboratory hematology
Published: March 05, 2023

Educating the educator about patient blood management.

Educating the educator about patient blood management.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: January 30, 2022

COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.

COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.

Journal: Leukemia & lymphoma
Published: August 18, 2021

Deletions and amplifications of the IGH variable and constant regions:a novel prognostic parameter in patients with multiple myeloma.

Deletions and amplifications of the IGH variable and constant regions:a novel prognostic parameter in patients with multiple myeloma.

Journal: Leukemia research
Published: September 20, 2020

Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study.

Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study.

Journal: Clinical lymphoma, myeloma & leukemia
Published: April 30, 2020

Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group.

Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group.

Journal: American journal of hematology
Published: December 18, 2019

Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation.

Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation.

Journal: Experimental hematology
Published: February 11, 2018
Showing 1-12 of 23

Last Updated: 09/26/2026